The enhanced tumor accumulation following PGA-Dtx administration significantly suppressed tumor growth <i>in vivo</i>, normalized cathepsin K activity levels, and reduced bone damage while avoiding the systemic toxicity associated with free Dtx. The gene discussed is CTSK; the disease is neoplasm.